Affymetrix executives in recent weeks have predicted that the firm's agreement with the UK Biobank to genotype its 500,000-sample collection on its Axiom platform could sway other biorepositories to choose its arrays for similar projects.

That appears to have been the case in the decision of BioProcessing Solutions Alliance to use the Santa Clara, Calif.-based microarray vendor's chips to genotype 100,000 samples on behalf of the US Department of Veterans Affairs as part of the VA's Million Veteran Program.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.